Haemonetics Corp.

NYSE: HAE
Share price (6/12/24): $85.93
Market cap (6/12/24): $4.378 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

16 Haemonetics Corp. Expert Interviews, now on BamSEC.

Powered by Tegus.

Indentures Filter

from 8-K 103 pages Haemonetics Corporation and U.S. Bank Trust Company, National Association as Trustee Indenture Dated as of May 28, 2024 2.50% Convertible Senior Notes Due 2029

from 8-K 103 pages Haemonetics Corporation and U.S. Bank National Association as Trustee Indenture Dated as of March 5, 2021 0.00% Convertible Senior Notes Due 2026

from 10-K 2 pages Description of Registrant’s Common Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-8 22 pages Article 1. Establishment, Objectives, and Duration

from S-8 20 pages Article 1. Establishment, Objectives, and Duration

from S-8 6 pages Disclosure Document February 11, 2008 (This Document Is Delivered Pursuant to Form S-8 Part I, and Constitutes Part of a Prospectus Covering Securities That Have Been Registered Under the Securities Act of 1933.) Haemonetics Corporation 2007 Employee Stock Purchase Plan

from S-8 17 pages I Article 1. Establishment, Objectives, and Duration

from S-8 ~10 pages 2000 Long Term Incentive Plan

from S-8 ~10 pages Indenture or similar

from S-8 ~5 pages Indenture or similar

from 8-K ~50 pages Shareholder Rights Agreement